CD274 and neoplasm: It has low toxicity to the tested cell lines, inhibits the interaction between programmed cell death ligand (PD-L1) and programmed cell death receptor (PD-1), reduces the inhibitory effect of PD-L1 on T cell receptor-mediated T lymphocyte activation, and enhances tumor immune response, thus exerting anticancer effect6,7,8.